Literature DB >> 33508041

Hematopoietic cell-mediated dissemination of murine cytomegalovirus is regulated by NK cells and immune evasion.

Shunchuan Zhang1, Lauren E Springer1, Han-Zhi Rao1, Renee G Espinosa Trethewy2, Lindsey M Bishop2, Meaghan H Hancock2, Finn Grey3, Christopher M Snyder1.   

Abstract

Cytomegalovirus (CMV) causes clinically important diseases in immune compromised and immune immature individuals. Based largely on work in the mouse model of murine (M)CMV, there is a consensus that myeloid cells are important for disseminating CMV from the site of infection. In theory, such dissemination should expose CMV to cell-mediated immunity and thus necessitate evasion of T cells and NK cells. However, this hypothesis remains untested. We constructed a recombinant MCMV encoding target sites for the hematopoietic specific miRNA miR-142-3p in the essential viral gene IE3. This virus disseminated poorly to the salivary gland following intranasal or footpad infections but not following intraperitoneal infection in C57BL/6 mice, demonstrating that dissemination by hematopoietic cells is essential for specific routes of infection. Remarkably, depletion of NK cells or T cells restored dissemination of this virus in C57BL/6 mice after intranasal infection, while dissemination occurred normally in BALB/c mice, which lack strong NK cell control of MCMV. These data show that cell-mediated immunity is responsible for restricting MCMV to hematopoietic cell-mediated dissemination. Infected hematopoietic cells avoided cell-mediated immunity via three immune evasion genes that modulate class I MHC and NKG2D ligands (m04, m06 and m152). MCMV lacking these 3 genes spread poorly to the salivary gland unless NK cells were depleted, but also failed to replicate persistently in either the nasal mucosa or salivary gland unless CD8+ T cells were depleted. Surprisingly, CD8+ T cells primed after intranasal infection required CD4+ T cell help to expand and become functional. Together, our data suggest that MCMV can use both hematopoietic cell-dependent and -independent means of dissemination after intranasal infection and that cell mediated immune responses restrict dissemination to infected hematopoietic cells, which are protected from NK cells during dissemination by viral immune evasion. In contrast, viral replication within mucosal tissues depends on evasion of T cells.

Entities:  

Year:  2021        PMID: 33508041      PMCID: PMC7872266          DOI: 10.1371/journal.ppat.1009255

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  102 in total

1.  Persistent viral replication and the development of T-cell responses after intranasal infection by MCMV.

Authors:  Shunchuan Zhang; Sofia Caldeira-Dantas; Corinne J Smith; Christopher M Snyder
Journal:  Med Microbiol Immunol       Date:  2019-03-08       Impact factor: 3.402

2.  Respiratory tract infections in cytomegalovirus-excreting and nonexcreting infants.

Authors:  C Wejse; N H Birkebaek; L P Nielsen; H M Andersen
Journal:  Pediatr Infect Dis J       Date:  2001-03       Impact factor: 2.129

3.  CMV sinusitis as the initial manifestation of AIDS.

Authors:  A Jütte; G Fätkenheuer; K Hell; B Salzberger
Journal:  HIV Med       Date:  2000-03       Impact factor: 3.180

4.  Murine cytomegalovirus interference with antigen presentation contributes to the inability of CD8 T cells to control virus in the salivary gland.

Authors:  Xiuju Lu; Amelia K Pinto; Ann M Kelly; Kathy S Cho; Ann B Hill
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  CD4+ T help promotes influenza virus-specific CD8+ T cell memory by limiting metabolic dysfunction.

Authors:  Jolie G Cullen; Hayley A McQuilten; Kylie M Quinn; Moshe Olshansky; Brendan E Russ; Alison Morey; Sanna Wei; Julia E Prier; Nicole L La Gruta; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-20       Impact factor: 11.205

Review 6.  Cytomegalovirus sinusitis. A new manifestation of AIDS.

Authors:  S C Marks; S Upadhyay; L Crane
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-07

7.  Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice.

Authors:  J E Allan; G R Shellam
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response.

Authors:  Marielle C Gold; Michael W Munks; Markus Wagner; Christopher W McMahon; Ann Kelly; Daniel G Kavanagh; Mark K Slifka; Ulrich H Koszinowski; David H Raulet; Ann B Hill
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

Review 9.  Human cytomegalovirus tropism for mucosal myeloid dendritic cells.

Authors:  Laura Hertel
Journal:  Rev Med Virol       Date:  2014-06-02       Impact factor: 6.989

10.  Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells.

Authors:  Senta M Walton; Sanja Mandaric; Nicole Torti; Albert Zimmermann; Hartmut Hengel; Annette Oxenius
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

View more
  6 in total

1.  Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.

Authors:  Scott G Hansen; Meaghan H Hancock; Daniel Malouli; Emily E Marshall; Colette M Hughes; Kurt T Randall; David Morrow; Julia C Ford; Roxanne M Gilbride; Andrea N Selseth; Renee Espinosa Trethewy; Lindsey M Bishop; Kelli Oswald; Rebecca Shoemaker; Brian Berkemeier; William J Bosche; Michael Hull; Lorna Silipino; Michael Nekorchuk; Kathleen Busman-Sahay; Jacob D Estes; Michael K Axthelm; Jeremy Smedley; Danica Shao; Paul T Edlefsen; Jeffrey D Lifson; Klaus Früh; Jay A Nelson; Louis J Picker
Journal:  Sci Immunol       Date:  2022-06-17

2.  New intranasal and injectable gene therapy for healthy life extension.

Authors:  Dabbu Kumar Jaijyan; Anca Selariu; Ruth Cruz-Cosme; Mingming Tong; Shaomin Yang; Alketa Stefa; David Kekich; Junichi Sadoshima; Utz Herbig; Qiyi Tang; George Church; Elizabeth L Parrish; Hua Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-10       Impact factor: 12.779

3.  Comparability of CMV DNA Extraction Methods and Validation of Viral Load.

Authors:  Théophile Uwiringiyeyezu; Bouchra El Khalfi; Rachid Saile; Jamal Belhachmi; Abdelaziz Soukri
Journal:  Methods Protoc       Date:  2022-01-04

4.  Multiple Autonomous Cell Death Suppression Strategies Ensure Cytomegalovirus Fitness.

Authors:  Pratyusha Mandal; Lynsey N Nagrani; Liliana Hernandez; Anita Louise McCormick; Christopher P Dillon; Heather S Koehler; Linda Roback; Emad S Alnemri; Douglas R Green; Edward S Mocarski
Journal:  Viruses       Date:  2021-08-27       Impact factor: 5.818

5.  Retinal and Choroidal Pathologies in Aged BALB/c Mice Following Systemic Neonatal Murine Cytomegalovirus Infection.

Authors:  Jinxian Xu; Xinglou Liu; Xinyan Zhang; Brendan Marshall; Zheng Dong; Sylvia B Smith; Diego G Espinosa-Heidmann; Ming Zhang
Journal:  Am J Pathol       Date:  2021-06-28       Impact factor: 5.770

Review 6.  Pathogenic Exploitation of Lymphatic Vessels.

Authors:  Alexandra I Magold; Melody A Swartz
Journal:  Cells       Date:  2022-03-12       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.